ClinVar Miner

Submissions for variant NM_024577.3(SH3TC2):c.1002-5T>A (rs769711653)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000659033 SCV000293013 uncertain significance not provided 2017-11-13 criteria provided, single submitter clinical testing The c.1002-5 T>A variant has not been published as pathogenic, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Multiple in-silico splice prediction models predict that c.1002-5 T>A may weaken or destroy the natural splice acceptor site in intron 8 and lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic or a rare benign variant.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000659033 SCV000780837 uncertain significance not provided 2017-11-01 criteria provided, single submitter clinical testing
Invitae RCV000818193 SCV000958792 uncertain significance Charcot-Marie-Tooth disease type 4 2018-10-29 criteria provided, single submitter clinical testing This sequence change falls in intron 8 of the SH3TC2 gene. It does not directly change the encoded amino acid sequence of the SH3TC2 protein. This variant is present in population databases (rs769711653, ExAC 0.009%). This variant has not been reported in the literature in individuals with SH3TC2-related disease. ClinVar contains an entry for this variant (Variation ID: 245849). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Athena Diagnostics Inc RCV000659033 SCV001145600 uncertain significance not provided 2018-11-27 criteria provided, single submitter clinical testing
Molecular Genetics Laboratory,London Health Sciences Centre RCV001173169 SCV001336249 uncertain significance Charcot-Marie-Tooth disease criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.